Kyverna Therapeutics, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 11/08/2026 | Mar 2026Filed 11/08/2026 | Sep 2025Filed 12/11/2025 | Jun 2025Filed 11/08/2026 | Mar 2025Filed 11/08/2026 | Sep 2024Filed 12/11/2025 | Jun 2024Filed 12/11/2025 | Mar 2024Filed 12/11/2025 |
|---|---|---|---|---|---|---|---|---|
| −$38 | −$40 | −$37 | −$42 | −$45 | −$34 | −$29 | −$27 | |
| −$0.63 | −$0.66 | −$0.85 | −$0.97 | −$1.03 | −$0.80 | −$0.67 | −$1.12 | |
| 61 | 60 | 43 | 43 | 43 | 43 | 43 | 24 |
Trend